Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments
Overview
General Medicine
Affiliations
Although recent studies have indicated that the major histocompatibility complex-like, beta2-microglobulin-associated CD1 molecules might function to present a novel chemical class of antigens, lipids and glycolipids, to alpha/beta T cells, little is known about the T cell subsets that interact with CD1. A subset of CD1d-autoreactive, natural killer (NK)1.1 receptor-expressing alpha/beta T cells has recently been identified. These cells, which include both CD4(-)CD8(-) and CD4(+) T cells, preferentially use an invariant Valpha14-Jalpha281 T cell receptor (TCR) alpha chain paired with a Vbeta8 TCR beta chain in mice, or the homologous Valpha24-JalphaQ/Vbeta11 in humans. This cell subset can explosively release key cytokines such as interleukin (IL)-4 and interferon (IFN)-gamma upon TCR engagement and may regulate a variety of infectious and autoimmune conditions. Here, we report the existence of a second subset of CD1d-restricted CD4(+) T cells that do not express the NK1.1 receptor or the Valpha14 TCR. Like the Valpha14(+) NK1.1(+) T cells, these T cells exhibit a high frequency of autoreactivity to CD1d, use a restricted albeit distinct set of TCR gene families, and contribute to the early burst of IL-4 and IFN-gamma induced by intravenous injection of anti-CD3. However, the Valpha14(+) NK1.1(+) and Valpha14(-) NK1.1(-) T cells differ markedly in their requirements for self-antigen presentation. Antigen presentation to the Valpha14(+) NK1.1(+) cells requires endosomal targeting of CD1d through a tail-encoded tyrosine-based motif, whereas antigen presentation to the Valpha14(-) NK1.1(-) cells does not. These experiments suggest the existence of two phenotypically different subsets of CD1d-restricted T cells that survey self-antigens loaded in distinct cellular compartments.
Govindarajan S, Verheugen E, Venken K, Gaublomme D, Maelegheer M, Cloots E EMBO Rep. 2020; 21(6):e48927.
PMID: 32363653 PMC: 7271650. DOI: 10.15252/embr.201948927.
USP22 controls iNKT immunity through MED1 suppression of histone H2A monoubiquitination.
Zhang Y, Wang Y, Gao B, Sun Y, Cao L, Genardi S J Exp Med. 2020; 217(5).
PMID: 32069354 PMC: 7201925. DOI: 10.1084/jem.20182218.
A TCR β-Chain Motif Biases toward Recognition of Human CD1 Proteins.
Reinink P, Shahine A, Gras S, Cheng T, Farquhar R, Lopez K J Immunol. 2019; 203(12):3395-3406.
PMID: 31694911 PMC: 6904517. DOI: 10.4049/jimmunol.1900872.
Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin.
Melum E, Jiang X, Baker K, Macedo M, Fritsch J, Dowds C Nat Immunol. 2019; 20(12):1644-1655.
PMID: 31636468 PMC: 7249499. DOI: 10.1038/s41590-019-0504-0.
Singh A, Rhost S, Lofbom L, Cardell S Scand J Immunol. 2019; 90(3):e12794.
PMID: 31141185 PMC: 6851763. DOI: 10.1111/sji.12794.